HIGHOutside partySupplier
Endospan (NEXUS family)
“10-K Item 1A: 'the NEXUS family of products are solely manufactured by Endospan in Herzliya, Israel'”
AORT · Concentration risk · 10-K extracted
Artivion (AORT) concentration risks
Updated
The most significant concentration Artivion discloses is Endospan (NEXUS family), classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Artivion’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 8 disclosed concentrations
HIGH4
MEDIUM4
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
HIGHOutside partySupplier
AMDS sole manufacturer
“10-K Item 1A: 'The AMDS product is solely manufactured by a supplier in Charlotte, North Carolina'”
HIGHOutside partySupplier
BioGlue single-supplier delivery devices
“10-K Item 1A: 'We are significantly dependent on our revenues from BioGlue ... The delivery devices are manufactured by a single supplier, using resin supplied by a different single supplier'”
HIGHOutside partySupplier
On-X AAP single-supplier grafts
“10-K Item 1A: 'We purchase grafts for our On-X AAP from a single supplier'”
MEDIUMBuilt-inProduct / Revenue mix
BioGlue
“10-K Item 1A: 'BioGlue is a significant source of our revenues'”
MEDIUMBuilt-inProduct / Revenue mix
On-X products
“10-K Item 1A: 'On-X products are a significant source of our revenues'”
MEDIUMBuilt-inProduct / Revenue mix
aortic stent grafts
“10-K Item 1A: 'Aortic stent grafts are a significant source of our revenues'”
MEDIUMBuilt-inProduct / Revenue mix
tissue preservation services
“10-K Item 1A: 'Tissue preservation services are a significant source of our revenues'”
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-06-24The company's concentration profile is anchored by an unusually deep supply-chain dependency structure: four of the disclosed claims involve sole or single-source manufacturing relationships for distinct products, each carrying a high disclosed size. The NEXUS family of products is solely manufactured by Endospan in Herzliya, Israel; the AMDS product is solely manufactured by a single supplier in Charlotte, North Carolina; BioGlue delivery devices are manufactured by a single supplier using resin from a different single supplier; and grafts for the On-X AAP are purchased from a single supplier. These four sole-source relationships span the company's core product lines with no disclosed alternative manufacturer for any of them. Layered on the supply dependency is a revenue dependency across multiple product lines: BioGlue, On-X products, aortic stent grafts, and tissue preservation services are each described as a significant source of revenues, all at the medium-share band by disclosed size. The product revenue base is distributed across several franchises, which provides some diversification on the demand side — but each of those franchises is itself dependent on a single-source manufacturer on the supply side. The interaction is the core analytical point: the company's revenue is spread across multiple product lines, but supply disruption risk is concentrated through sole-source manufacturing at each of those product lines independently. A regulatory, operational, or geopolitical event affecting any one sole-source supplier would remove the ability to supply one product line without an alternative manufacturing path, making the supply-side dependency the dominant concentration risk in the profile.
For the engine’s reasoning on AORT’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Devices
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| AORT● | Artivion, Inc. | 4 | 4 | 0 | 8 |
| ATEC | Alphatec Holdings, Inc. | 1 | 1 | 0 | 2 |
| ABT | Abbott Laboratories | 1 | 0 | 0 | 1 |
| AXGN | AxoGen, Inc. | 0 | 0 | 0 | 0 |
| BIO | Bio-Rad Laboratories, Inc. | 0 | 0 | 0 | 0 |
| BIO-B | Bio-Rad Laboratories, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.